ABEONA THERAPEUTICS INC.ABEO

Market cap

$255.78M

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Revenue	2	4	2	925,000	1	889,000	837,000	3	-	10	3	1	4	-
Revenue growth (%)	-								-	-				-
Cost of revenue	1	267,000	125,000	-	-	-	-	-	-	-	-	-	-	-
Research & development	4	2	884,000	333,000	5	11	17	39	49	30	34	29	31	34
Selling, general & administrative	-	6	5	4	-	-	-	-	-	-	-	-	-	-
Operating margin (%)									-					-
Operating income	-7,876,000	-4,316,000	-3,804,000	-3,131,000	-18,546,000	-23,881,000	-27,836,000	-58,166,000	-77,090,000	-81,420,000	-89,836,000	-51	-47	-64
Operating expenses	10	9	6	4	20	25	29	61	77	91	93	52	51	64
Income before tax	-2,515,000	-10,532,000	-	-	-	-	-	-	-	-	-	-	-	-
Pretax margin (%)	-136.1	-239.1	-	-	-	-	-	-	-	-	-	-	-	-
Provision for income taxes	17,000	-	-	-	-	-	-	-	-	-	-	-	-	-
Effective tax rate (%)		-	-	-	-	-	-	-	-	-	-	-	-	-
Net income	-2,532,000	-10,532,000	4	-26,778,000	-14,526,000	-21,873,000	-27,319,000	-56,671,000	-76,282,000	-84,234,000	-84,936,000	-40	-54	-64
Net income margin (%)									-					-
Earnings per share	-	-	0.06	-15.26	-	-	-	-	-	-	-	-5.53	-2.53	-1.55
Diluted EPS	-	-	0.06	-15.26	-	-	-	-	-	-	-	-5.53	-2.53	-1.55
EBITDA
EBITDA margin (%)									-					-